Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4–1BB: A preclinical study in multiple myeloma

Autor: Saltarella, Ilaria, Link, Alexander, Lamanuzzi, Aurelia, Reichen, Christian, Robinson, Joanna, Altamura, Concetta, Melaccio, Assunta, Solimando, Antonio Giovanni, Ria, Roberto, Mariggiò, Maria Addolorata, Vacca, Angelo, Frassanito, Maria Antonia, Desaphy, Jean-François
Zdroj: In Biomedicine & Pharmacotherapy July 2024 176
Databáze: ScienceDirect